#drug development — Saturday, June 20, 2026 (1 items)
| 0 | 💬 0 |
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trial.
(linkinghub.elsevier.com)
|
The Lancet 2026-06-20 | #metabolism #clinical trial #diabetes #drug development |